Get the live share price of DaVita HealthCare Partners Inc (DVA), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
MLYS, LYEL, NKTR and INSM rise more than 50% in 2025 as clinical wins, FDA approvals and M&A deals revive sector momentum heading into 2026.
Get the live share price of AstraZeneca PLC ADR (AZN), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
FDA approves FUROSCIX- for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 ...
NORTHAMPTON, MA / ACCESS Newswire / December 22, 2025 / DaVita:For individuals managing chronic kidney disease (CKD), dietary ...
Builds upon existing granted DSR patents in US, Europe, Japan and ChinaStrengthens DSR patent protection based upon extensive clinical and pre-clinical experienceData published in European Journal of ...
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...
A male in his 50s presented to the renal department with a diagnostic challenge of an unexplained kidney injury.
Following this week's European Commission approval of Roche/Genentech's Gazyvaro (obinutuzumab) for the treatment of lupus nephritis (LN), Spherix Global Insights' latest RealTime Dynamix(TM): Lupus ...
Serum levels of suppressor of cytokine signalling 2 are significantly elevated in children with CKD and are independently ...
Send us a tip using our anonymous form. A daily briefing on what matters in the music industry Send us a tip using our anonymous form. Billboard is a part of Penske ...
This document describes performance measures for chronic coronary disease that are appropriate for public reporting or pay-for-performance programs. Quality measures are also provided that are not yet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results